Texas SB122 mandates labeling for products containing or derived from aborted human fetal tissue.

Texas SB122 amends the Health and Safety Code to require clear and conspicuous labeling for products containing or derived from aborted human fetal tissue. This includes food products, medical products, and cosmetic products. The bill defines "human fetal tissue" as tissue, cells, or organs obtained from an aborted unborn child. The executive commissioner of the Health and Human Services Commission must prescribe the form and contents of the labels by December 1, 2025. These labeling requirements apply only to products sold, dispensed, or administered on or after January 1, 2026.

Texas SB122 mandates labeling for products containing or derived from aborted human fetal tissue.

Texas SB122 amends the Health and Safety Code to require clear and conspicuous labeling for products containing or derived from aborted human fetal tissue. This includes food products, medical products, and cosmetic products. The bill defines "human fetal tissue" as tissue, cells, or organs obtained from an aborted unborn child. The executive commissioner of the Health and Human Services Commission must prescribe the form and contents of the labels by December 1, 2025. These labeling requirements apply only to products sold, dispensed, or administered on or after January 1, 2026.